Investigation finds “unexplained” millions in drug industry payments to the NHS
Many trusts didn’t recognise or couldn’t verify the payments Findings raise important questions about unrecognised conflicts of interest Pharmaceutical companies have paid an estimated £156 million to NHS trusts in England between 2015 and 2022 without the public being told what the payments are for, reveals an investigation by The BMJ today. ...